THE DOPAMINE AGONIST: IMPORTANT ADVANCE IN THE TREATMENT OF PARKINSON’S DISEASE Newsletter Article 14 February 2013 Pages: 2 - 2
SYSTEMIC SIDE-EFFECTS OF BECLOMETHASONE DIPROPIONATE AEROSOL Newsletter Article 14 February 2013 Pages: 4 - 4
DIGOXIN BIOAVAILABILITY AFFECTED BY ANTACIDS AND KAOLIN-PECTIN MIXTURES Newsletter Article 14 February 2013 Pages: 5 - 5
DIAZEPAM AND PHENYTOIN: AETIOLOGY OF CLEFT LIP AND/OR CLEFT PALATE Newsletter Article 14 February 2013 Pages: 6 - 6
DEMENTIA IN PARKINSONIAN PATIENTS ON LONG-TERM LEVODOPA Newsletter Article 14 February 2013 Pages: 6 - 6
INDUCTION OF ABORTION WITH 15(S)-15-METHYL PROSTAGLANDIN F2α Newsletter Article 14 February 2013 Pages: 8 - 8
AMIKACIN TREATMENT OF INFECTIONS IN NEUTROPAENIC PATIENTS Newsletter Article 14 February 2013 Pages: 9 - 9
METOPROLOL AND CEDILANID-D IN PATIENTS WITH ANGINA Newsletter Article 14 February 2013 Pages: 11 - 11
EFFECTS OF METOPROLOL IN PATIENTS WITH ANGINA PECTORIS Newsletter Article 14 February 2013 Pages: 11 - 11
INTER-SUBJECT VARIATION IN PENTAZOCINE ELIMINATION Newsletter Article 14 February 2013 Pages: 12 - 12
REDUCTION OF MENSTRUAL BLOOD LOSS BY PROSTAGLANDIN SYNTHETASE INHIBITORS Newsletter Article 14 February 2013 Pages: 12 - 12
ORAL CONTRACEPTIVES AND PITUITARY SECRETION OF PROLACTIN Newsletter Article 14 February 2013 Pages: 12 - 12
CHANGES IN AIRWAYS RESISTANCE FOLLOWING PSYCHOTROPIC DRUGS Newsletter Article 14 February 2013 Pages: 13 - 13